Voloridge Investment Management Portfolio holdings
AUM
$27.1B
This Quarter Return
+4.39%
1 Year Return
+25.54%
3 Year Return
+79.26%
5 Year Return
+135.5%
10 Year Return
+413.11%
AUM
$28.3B
AUM Growth
+$28.3B
(+2.8%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
4.29%
Top 10 Holdings %
Top 10 Hldgs %
8.95%
Holding
1,427
New
294
Increased
403
Reduced
453
Closed
277
Top Buys
| 1 |
Tesla
TSLA
|
$308M |
| 2 |
Booking.com
BKNG
|
$228M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$199M |
| 4 |
Linde
LIN
|
$166M |
| 5 |
KLA
KLAC
|
$166M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$227M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$217M |
| 3 |
Apple
AAPL
|
$184M |
| 4 |
Mastercard
MA
|
$180M |
| 5 |
CME Group
CME
|
$117M |
Sector Composition
| 1 | Technology | 18.93% |
| 2 | Consumer Discretionary | 15.74% |
| 3 | Industrials | 14.89% |
| 4 | Healthcare | 14.38% |
| 5 | Financials | 12.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Applied Therapeutics
APLT
$72.8M
| – | – |
-34,463
| Closed | -$293K |
|
1377
Applovin
APP
$164B
| – | – |
-236,624
| Closed | -$30.9M |
|
1378
Arrowhead Research
ARWR
$3.84B
| – | – |
-127,602
| Closed | -$2.47M |
|
1379
Academy Sports + Outdoors
ASO
$3.32B
| – | – |
-563,477
| Closed | -$32.9M |
|
1380
Algoma Steel
ASTL
$502M
| – | – |
-38,272
| Closed | -$392K |
|
1381
AST SpaceMobile
ASTS
$12.3B
| – | – |
-39,078
| Closed | -$1.02M |
|
|
AUTL
1382
Autolus Therapeutics
AUTL
$383M
| – | – |
-121,035
| Closed | -$439K |
|
1383
Avanos Medical
AVNS
$572M
| – | – |
-27,984
| Closed | -$672K |
|
1384
Acuity Brands
AYI
$10.1B
| – | – |
-40,110
| Closed | -$11M |
|
|
AZEK
1385
DELISTED
The AZEK Co
AZEK
| – | – |
-160,891
| Closed | -$7.53M |
|
|
AZUL
1386
DELISTED
Azul
AZUL
| – | – |
-99,325
| Closed | -$342K |
|
1387
Atlanta Braves Holdings Series B
BATRK
$2.71B
| – | – |
-11,098
| Closed | -$442K |
|
1388
BCE
BCE
$22.9B
| – | – |
-879,283
| Closed | -$30.6M |
|
1389
Barclays
BCS
$68.9B
| – | – |
-2,505,608
| Closed | -$30.4M |
|
1390
B&G Foods
BGS
$355M
| – | – |
-20,026
| Closed | -$178K |
|
1391
Bio-Rad Laboratories Class A
BIO
$7.8B
| – | – |
-13,185
| Closed | -$4.41M |
|
1392
Bausch + Lomb
BLCO
$5.19B
| – | – |
-125,955
| Closed | -$2.43M |
|
1393
Blackrock
BLK
$170B
| – | – |
-18,693
| Closed | -$17.7M |
|
1394
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-289,735
| Closed | -$15M |
|
1395
Braze
BRZE
$2.85B
| – | – |
-48,960
| Closed | -$1.58M |
|
1396
AB InBev
BUD
$116B
| – | – |
-218,319
| Closed | -$14.5M |
|
1397
Citigroup
C
$174B
| – | – |
-180,028
| Closed | -$11.3M |
|
1398
Cabaletta Bio
CABA
$138M
| – | – |
-61,842
| Closed | -$292K |
|
1399
CBRE Group
CBRE
$47.2B
| – | – |
-264,275
| Closed | -$32.9M |
|
1400
Coca-Cola Europacific Partners
CCEP
$39.4B
| – | – |
-148,056
| Closed | -$11.7M |
|